(Q34092346)

31 July 2017

1 reference

title

Disorders of glucose metabolism in patients infected with human immunodeficiency virus (English)

1 reference

31 July 2017

0 references

Dubé MP

1

1 reference

31 July 2017

language of work or name

English

0 references

publication date

29 November 2000

1 reference

Clinical Infectious Diseases

31 July 2017

published in

1 reference

31 July 2017

volume

31

1 reference

31 July 2017

issue

6

1 reference

31 July 2017

page(s)

1467-1475

1 reference

Hyperglycemia associated with protease inhibitors in an urban HIV-infected minority patient population

31 July 2017

cites work

1 reference

Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients.

21 January 2018

1 reference

Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection

21 January 2018

1 reference

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

21 January 2018

1 reference

Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors.

21 January 2018

1 reference

Insulin resistance in HIV protease inhibitor-associated diabetes

21 January 2018

1 reference

Fasting hyperinsulinemia and changes in regional body composition in human immunodeficiency virus-infected women

21 January 2018

1 reference

Fasting hyperinsulinemia in human immunodeficiency virus-infected men: relationship to body composition, gonadal function, and protease inhibitor use.

21 January 2018

1 reference

Fasting hyperinsulinemia and increased waist-to-hip ratios in non-wasting individuals with AIDS.

21 January 2018

1 reference

Preliminary guidelines for the evaluation and management of dyslipidemia in adults infected with human immunodeficiency virus and receiving antiretroviral therapy: Recommendations of the Adult AIDS Clinical Trial Group Cardiovascular Disease Focus G

21 January 2018

1 reference

Insulin resistance implications for type II diabetes mellitus and coronary heart disease

21 January 2018

1 reference

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study

21 January 2018

1 reference

Reversion of metabolic abnormalities after switching from HIV-1 protease inhibitors to nevirapine.

21 January 2018

1 reference

The Short Insulin Tolerance Test for Determination of Insulin Sensitivity: A Comparison with the Euglycaemic Clamp

21 January 2018

1 reference

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

Endocrine and metabolic evaluation of human immunodeficiency virus-infected patients with evidence of protease inhibitor-associated lipodystrophy

21 January 2018

1 reference

"Buffalo hump" in men with HIV-1 infection.

21 January 2018

1 reference

Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp

21 January 2018

1 reference

Facilitative glucose transporters

21 January 2018

1 reference

The mechanism of insulin resistance caused by HIV protease inhibitor therapy.

21 January 2018

1 reference

Pentamidine-induced derangements of glucose homeostasis. Determinant roles of renal failure and drug accumulation. A study of 128 patients

21 January 2018

1 reference

Hypoglycaemia and diabetes mellitus following parenteral pentamidine mesylate treatment in AIDS patients

21 January 2018

1 reference

Diabetes mellitus in a patient with AIDS after treatment with pentamidine aerosol

21 January 2018

1 reference

Severe hyperglycemia in an HIV clinic: preexisting versus drug-associated diabetes mellitus

21 January 2018

1 reference

Hyperosmolar nonketotic diabetic syndrome following treatment of human immunodeficiency virus infection with didanosine

21 January 2018

1 reference

Insulin sensitivity and insulin clearance in human immunodeficiency virus-infected men

21 January 2018

1 reference

Earlier appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM. 5-Year follow-up of initially nondiabetic Japanese-American men.

21 January 2018

1 reference

Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy

21 January 2018

1 reference

A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy.

21 January 2018

1 reference

A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome.

21 January 2018

1 reference

Lipodystrophy in patients naive to HIV protease inhibitors

21 January 2018

1 reference

Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy

21 January 2018

1 reference

Lactic acidosis rates in type 2 diabetes.

21 January 2018

1 reference

Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation.

21 January 2018

1 reference

Hepatotoxicity due to troglitazone: report of two cases and review of adverse events reported to the United States Food and Drug Administration

21 January 2018

1 reference

21 January 2018

1 reference

Rosiglitazone and hepatic failure.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/317491

1 reference

31 July 2017

1 reference